<DOC>
	<DOCNO>NCT00258934</DOCNO>
	<brief_summary>All market influenza vaccine inject intramuscular ( IM ) route . This study test whether influenza vaccine effective inject route muscle . In order prove , amount antibody blood measure vaccination . In addition , safety influenza vaccine test evaluate serious reaction occur vaccination . The vaccine inject study similar sponsor 's market intramuscular influenza vaccine ( Vaxigrip ) . In addition , safety influenza vaccine administer different route test evaluate adverse event especially serious reaction . Primary Objective : To demonstrate compare immune response influenza vaccine single dose administer different route . Secondary Objectives : To describe compliance immunogenicity vaccine European Medicine Agency ( EMEA ) first injection .</brief_summary>
	<brief_title>Immunogenicity Study Influenza Vaccine Adults</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Orthomyxoviridae Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Aged 18 57 year day inclusion Informed consent form sign Able attend schedule visit comply trial procedure For woman , inability bear child negative urine pregnancy test V01 For woman childbearing potential : use effective method contraception abstinence least 4 week prior , least four week , first vaccination . At Year 1 ( Visit 05 ) : Addendum inform consent form sign date subject prior vaccination Visit 05 At Year 2 ( Visit 07 ) : Addendum inform consent form sign date subject prior vaccination Visit 07 Systemic hypersensitivity egg protein , chick protein , vaccine component ; particular , neomycin , formaldehyde , octoxinol 9 , history lifethreatening reaction trial vaccine vaccine contain substance . Febrile illness ( rectal equivalent temperature &gt; = 38.0Â°C ) day inclusion Breastfeeding Participation another clinical trial four week precede first trial vaccination Planned participation another clinical trial present trial period Congenital acquire immunodeficiency ; immunosuppressive therapy anticancer chemotherapy radiation therapy within precede six month ; longterm systemic corticosteroid therapy . Chronic illness stage could interfere trial conduct completion Current abuse alcohol drug addiction may interfere subject 's ability comply trial procedure Blood bloodderived product receive past three month Any vaccination four week precede first trial vaccination Vaccination plan four week follow first trial vaccination Previous vaccination influenza ( previous six month ) trial vaccine another vaccine Thrombocytopenia bleeding disorder contraindicate IM vaccination Subject deprive freedom administrative court order ; emergency setting ; hospitalize without his/her consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>57 Years</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Orthomyxoviruses</keyword>
	<keyword>Inactivated</keyword>
	<keyword>Split-virion influenza vaccine</keyword>
	<keyword>adult</keyword>
	<keyword>Myxovirus Infection</keyword>
	<keyword>Orthomyxovirus Infection</keyword>
</DOC>